Publications

Dr. Lopez has authored/coauthored approximately 30 articles or abstracts for scientific meetings and has been published in such peer-reviewed journals as Pediatrics, the Journal of the American Academy of Child and Adolescent Psychiatry, the Journal of Pediatrics and the Journal of Clinical Psychiatry.

Publications

  • 1. Ambrosini PJ, Sallee FR, Lopez FA, Shi L, Michaels MA. A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD. Curr Med Res Opin. 2006 Feb;22(2):427-40.
  • 2. Antonucci D, Kunins C, Manos M, Lopez FA, Kerney DL. Assessing effects of treatment with lisdexamfetamine dimesylate for pediatric ADHD using a parental survey. CNS Spectr. Apr;15(4):248-56.
  • 3. Arnold LE, Lindsay RL, Lopez FA, et al. Treating attention-deficit/hyperactivity disorder with a stimulant transdermal patch: the clinical art. Pediatrics. 2007 Nov;120(5):1100-6.
  • 4. Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang Y. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry. 2007 Nov 1;62(9):970-6.
  • 5. Biederman J, Lopez FA, Boellner SW, Chandler MC. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002 Aug;110(2 Pt 1):258-66.
  • 6. Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J Clin Psychiatry. 2006 May;67(5):727-35.
  • 7. Brams M, Moon E, Pucci M, Lopez FA. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day. Curr Med Res Opin. Aug;26(8):1809-25.
  • 8. Brams M, Muniz R, Childress A, et al. A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect. CNS Drugs. 2008;22(8):693-704.
  • 9. Childress AC, Spencer T, Lopez F, et al. Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Aug;19(4):351-61.
  • 10. Connor DF, Findling RL, Kollins SH, et al. Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs. Sep;24(9):755-68.
  • 11. Diler RS, Daviss WB, Lopez A, Axelson D, Iyengar S, Birmaher B. Differentiating major depressive disorder in youths with attention deficit hyperactivity disorder. J Affect Disord. 2007 Sep;102(1-3):125-30.
  • 12. Faraone SV, Glatt SJ, Bukstein OG, Lopez FA, Arnold LE, Findling RL. Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD. J Atten Disord. 2009 Jan;12(4):308-15.
  • 13. Findling RL, Biederman J, Wilens TE, et al. Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr. 2005 Sep;147(3):348-54.
  • 14. Findling RL, Brams M, Childress AC, Lopez FA, Manos MJ, Jensen PS. Changes in emotions related to medication used to treat ADHD. Part II: clinical approaches. J Atten Disord. Feb;15(2):113-21.
  • 15. Findling RL, Bukstein OG, Melmed RD, et al. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008 Jan;69(1):149-59.
  • 16. Geller D, Donnelly C, Lopez F, et al. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2007 Sep;46(9):1119-27.
  • 17. Kollins SH, Lopez FA, Vince BD, et al. Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. Apr;21(2):111-20.
  • 18. Lopez F, Silva R, Pestreich L, Muniz R. Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatr Drugs. 2003;5(8):545-55.
  • 19. Lopez FA. ADHD: new pharmacological treatments on the horizon. J Dev Behav Pediatr. 2006 Oct;27(5):410-6.
  • 20. Lopez FA, Ginsberg LD, Arnold V. Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis. Postgrad Med. 2008 Sep;120(3):89-102.
  • 21. Lopez FA, Scheckner B, Childress AC. Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study. Neuropsychiatr Dis Treat.7:267-73.
  • 22. Manos MJ, Brams M, Childress AC, Findling RL, Lopez FA, Jensen PS. Changes in emotions related to medication used to treat ADHD. Part I: literature review. J Atten Disord. Feb;15(2):101-12.
  • 23. McGough JJ, Biederman J, Wigal SB, et al. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):530-8.
  • 24. Silva R, Muniz R, Pestreich LK, Brams M, Childress A, Lopez FA. Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting. J Child Adolesc Psychopharmacol. 2005 Aug;15(4):637-54.
  • 25. Silva RR, Muniz R, Pestreich L, et al. Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006 Jun;16(3):239-51.
  • 26. Swanson JM, Greenhill LL, Lopez FA, et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry. 2006 Jan;67(1):137-47.
  • 27. Wilens TE, Boellner SW, Lopez FA, et al. Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2008 Jun;47(6):700-8.

Awards

  • Patients’ Choice – Patients’ Choice recognizes doctors who make a difference in the lives of their patients. This honor is given to those physicians who have received near perfect scores as voted by their patients. For 10 ratings, Dr. Lopez has an average overall score of 3.5 stars.
  • Compassionate Doctor certification is part of 'Patients' Choice' where patients rate and vote for their favorite doctors. Patients have expressed their esteemed opinion of this doctor's bedside manner, identifying as one of America's Most Compassionate Doctors.


What is Developmental Pediatrics?

Developmental Pediatrics is a medical specialty focusing on assessment and treatment of children with developmental delays, developmental disabilities or chronic conditions affecting physical or emotional development, learning or behavior.

Contact

  • Phone (407) 644-4844
  • Fax (407) 644-6101
  • 2225 Glenwood Drive, Ste 200
    Winter Park, FL 32792